Order Article Reprints

Machado RAdS, Siqueira RP, da Silva FC, Matos ACPd, Borges DS, Rocha GG, Souza TCPd, Souza RAC, Oliveira CRd, Ferreira AG, et al. A New Heteroleptic Zn(II) Complex with Schiff Bases Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel. Pharmaceutics. 2024; 16(12):1610. https://doi.org/10.3390/pharmaceutics16121610

Machado, Raiane Aparecida dos Santos, Raoni Pais Siqueira, Fernanda Cardoso da Silva, André Carlos Pereira de Matos, Dayanne Silva Borges, Gislaine Gonçalves Rocha, Thais Cristina Prado de Souza, Rafael Aparecido Carvalho Souza, Clayton Rodrigues de Oliveira, Antônio G. Ferreira, and et al. 2024. "A New Heteroleptic Zn(II) Complex with Schiff Bases Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel" Pharmaceutics 16, no. 12: 1610. https://doi.org/10.3390/pharmaceutics16121610

Machado, R. A. d. S., Siqueira, R. P., da Silva, F. C., Matos, A. C. P. d., Borges, D. S., Rocha, G. G., Souza, T. C. P. d., Souza, R. A. C., Oliveira, C. R. d., Ferreira, A. G., Maia, P. I. d. S., Deflon, V. M., Oliveira, C. G., & Araújo, T. G. (2024). A New Heteroleptic Zn(II) Complex with Schiff Bases Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel. Pharmaceutics, 16(12), 1610. https://doi.org/10.3390/pharmaceutics16121610